Akili Inc's Customers Performance

Name: Akili Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

AKLI

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


AKLI's Source of Revenues		During the corresponding time, Akili Inc recorded a revenue increase by 238.94 % year on year, sequentially revenue fell by -48.87 %. While revenue at the Akili Inc 's corporate clients • List of AKLI Customers

for the same period Akili Inc recorded revenue increase by 238.94 % year on year, sequentially revenue fell by -48.87 %.

• List of AKLI Customers

Akili Inc's Business Units

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Akili Inc's Comment on Sales, Marketing and Customers

News about Akili Inc Contracts

Empowering Adults with ADHD The Game-Changer in Mental Health Treatment

The Future of ADHD Treatment: Akili Announces FDA Clearance for Over-the-Counter Digital TherapyIn a groundbreaking development for the field of mental health, Akili Inc. has received FDA authorization for the first over-the-counter digital treatment for adults with attention-deficit/hyperactivity disorder (ADHD). The clearance of EndeavorOTC (AKL-T01) marks a significant milestone in the growing field of digital therapeutics, as it demonstrates the efficacy and safety of using a video game as a treatment modality for a traditionally medication-based disorder.EndeavorOTC is a digital therapeutic delivered through an engaging video game experience that aims to improve attention function in adults with primari...

Akili Announces Strategic Amendments with Shionogi and Shows Promise with Sequential Revenue Growth

Leading digital medicine company, Akili Inc., recently announced several corporate updates, underscoring its evolving distribution agreement with pharmaceutical giant Shionogi and Co., Ltd. This amendment sees the cancellation of a significant long-term debt obligation and additional payments for the Japanese version of Akili s flagship product, AKL-T01. Alongside these developments, Akili Inc. has shown a 0.88% sequential revenue growth during the corresponding time period. This article aims to outline these key facts and shed light on Akili s shifting corporate strategy.Akili Inc. s amended strategic distribution agreement with Shionogi marks an important step for both companies. Under the revised terms, S...

AKLI's Stock Performance relative to it's Customers

AKLI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Akili Inc	33.92	1.95	-48.55	114
SUBTOTAL	0.00	0.00	0.00	-

Sources: Akili Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Akili Inc’s corporate clients.
For your research, we’ve provided 9 tables on Akili Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.